Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11794778.8Aexternal-prioritypatent/EP2651436B1/en
Application filed by Glaxosmithkline Biologicals S.A.filedCriticalGlaxosmithkline Biologicals S.A.
Publication of CY1117640T1publicationCriticalpatent/CY1117640T1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
Παρέχονται ανοσογόνες συνθέσεις οι οποίες περιέχουν ένα αντιγόνο συγγενές με Μ72, όπου η αγωγιμότητα της σύνθεσης είναι 13 mS/cm ή χαμηλότερη, ή η συγκέντρωση αλάτων της σύνθεσης είναι 130mM ή χαμηλότερη, και η χρήση τους στην ιατρική.Immunogenic compositions are provided containing an M72-like antigen, where the conductivity of the composition is 13 mS / cm or lower, or the salt concentration of the composition is 130 mM or less, and their use in medicine.
CY20161100533T2010-12-142016-06-15
ANTIGONIC COMPOSITION OF MYBACTERIA
CY1117640T1
(en)